A detailed history of Raab & Moskowitz Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 18,440 shares of BMY stock, worth $1.06 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
18,440
Previous 18,483 0.23%
Holding current value
$1.06 Million
Previous $956,000 9.0%
% of portfolio
0.26%
Previous 0.24%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$51.92 - $59.94 $2,232 - $2,577
-43 Reduced 0.23%
18,440 $1.04 Million
Q3 2024

Nov 15, 2024

SELL
$39.66 - $51.75 $43,546 - $56,821
-1,098 Reduced 5.61%
18,483 $956,000
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $23,546 - $30,999
-585 Reduced 2.9%
19,581 $813,000
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $22,550 - $25,568
470 Added 2.39%
20,166 $1.09 Million
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $67,968 - $81,105
-1,402 Reduced 6.65%
19,696 $1.01 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $144,030 - $161,048
-2,488 Reduced 10.55%
21,098 $1.22 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $119,137 - $132,283
-1,870 Reduced 7.35%
23,586 $1.51 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $36,403 - $41,289
-554 Reduced 2.13%
25,456 $1.76 Million
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $84,161 - $99,659
-1,229 Reduced 4.51%
26,010 $0
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $330 - $195,327
-2,542 Reduced 8.54%
27,239 $1.94 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $92,735 - $102,134
-1,277 Reduced 4.11%
29,781 $2.29 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $139,313 - $167,049
-2,266 Reduced 6.8%
31,058 $2.27 Million
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $159,495 - $185,934
-2,974 Reduced 8.19%
33,324 $2.08 Million
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $80,293 - $94,053
-1,357 Reduced 3.6%
36,298 $2.15 Million
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $338,152 - $368,248
-5,462 Reduced 12.67%
37,655 $2.52 Million
Q1 2021

Apr 28, 2021

SELL
$59.34 - $66.74 $114,822 - $129,141
-1,935 Reduced 4.3%
43,117 $2.72 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $126,797 - $143,684
-2,196 Reduced 4.65%
45,052 $2.79 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $212,376 - $235,340
-3,698 Reduced 7.26%
47,248 $2.85 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $110,297 - $128,949
-2,012 Reduced 3.8%
50,946 $3 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $402,566 - $585,022
-8,676 Reduced 14.08%
52,958 $2.95 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $34,496 - $44,997
701 Added 1.15%
61,634 $3.96 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $171,849 - $203,752
4,018 Added 7.06%
60,933 $3.09 Million
Q2 2019

Aug 09, 2019

SELL
$44.62 - $49.34 $36,900 - $40,804
-827 Reduced 1.43%
56,915 $2.58 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $3,744 - $4,465
83 Added 0.14%
57,742 $2.75 Million
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $44,664 - $57,918
-916 Reduced 1.56%
57,659 $3 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $59,715 - $67,354
1,082 Added 1.88%
58,575 $3.64 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $223,797 - $278,938
4,429 Added 8.35%
57,493 $3.18 Million
Q1 2018

Apr 25, 2018

BUY
$59.92 - $68.98 $36,910 - $42,491
616 Added 1.17%
53,064 $3.36 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $46,273 - $50,450
-772 Reduced 1.45%
52,448 $3.21 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $25,626 - $29,575
464 Added 0.88%
53,220 $3.28 Million
Q2 2017

Aug 16, 2017

BUY
N/A
52,756
52,756 $2.99 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Raab & Moskowitz Asset Management LLC Portfolio

Follow Raab & Moskowitz Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.